Store the sealed pen refrigerated at 28 C, protected from light
The benefits of Microdosing GLP-1 grow with time, consistency, and support
This ensures 100% bioavailability, quickly restoring your baseline energy, mental clarity, and metabolic function
GLP-1 receptor agonists were originally developed to help manage type 2 diabetes by enhancing insulin secretion and lowering blood sugar levels
-Linolenic acid versus -lipoic acid for treating painful diabetic neuropathy in adults: a 12-week, double-placebo, randomized, noninferiority trial
Side effect comparison: Nausea: Tirzepatide rates range from 12% to 33% depending on dose, comparable to cagrilintide Vomiting: Tirzepatide higher than cagrilintide Diarrhea: Similar rates Injection site reactions: Cagrilintide significantly higher than tirzepatide Fatigue: Tirzepatide fatigue is commonly reported, comparable to cagrilintide Some researchers are exploring cagrilintide combined with tirzepatide for potentially enhanced effects
